Basics Tourmaline Bio, Inc. Common Stock IPO Date: May 3, 2021 Sector: Healthcare Industry: Biotech Market Cap: $687.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.68 | 3.26% Avg Daily Range (30 D): $0.52 | 2.37% Avg Daily Range (90 D): $0.50 | 2.70% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .2M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 238 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.85M Avg Closing Trade (30 D): $.62M Avg Closing Trade (90 D): $.97M Avg Closing Volume: 97.39K     News Aug 31, 2025 @ 2:23 PM Tourmaline Bio Presents Data from the Ongoing Phas... Source: Tourmaline Bio Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 27, 2024 @ 12:05 PM Tourmaline Bio Announces the Promotion of Ryan Rob... Source: Tourmaline Bio, Inc. May 23, 2024 @ 11:10 AM Tourmaline Bio to Present at the Jefferies Global ... Source: Tourmaline Bio, Inc. May 13, 2024 @ 11:00 AM Tourmaline Bio Reports First Quarter 2024 Financia... Source: Tourmaline Bio, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.89 $-.78 $-.68 Diluted EPS $-.89 $-.78 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -22.97M $ -20.18M $ -17.49M Operating Income / Loss $ -26.23M $ -24.44M $ -21.97M Cost of Revenue $ $ $ Net Cash Flow $ 4.82M $ -35.14M $ -28.14M PE Ratio